NeuroSense Therapeutics
slowed the loss of physical functions placebo a | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
20 of 33
Similar slides by NeuroSense Therapeutics
See diffirences between slides (animation)
Investor Presentation
December 2023
slowed the loss of physical functions placebo at | NeuroSense Therapeutics
Related slides by other companies
Ocuphire Pharma
Investor Day
January 2022
study design assessed alone efficacy ace | Ocuphire Pharma
ATAI
Investor Presentation
February 2023
phase proof of concept trial design all subjects tid tid placebo trial status recruitment ongoing results anticipated randomized week study of and in patients with | ATAI
ATAI
Investor Presentation
January 2023
phase proof of concept trial design all subjects tid tid placebo trial status recruitment ongoing results anticipated randomized week study of and in patients with | ATAI
Ocuphire Pharma
Investor Day
January 2022
safety summary from phase and phase studies way | Ocuphire Pharma
Other recent decks by NeuroSense Therapeutics
See all presentations (3 decks)
Investor Presentation
December 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io